Wrongful Death Lawsuit Filed for Carter’s Toddler Son Over Singer’s Drug-Linked Drowning

The family of late singer Aaron Carter reached a settlement on May 14, 2026, with a psychiatry clinic to resolve a wrongful death lawsuit. The legal action was filed on behalf of Carter’s toddler son.

According to reporting from Rolling Stone, the settlement concludes a legal dispute regarding the prescriptions of alprazolam, commonly known as Xanax, provided to the singer prior to his death.

The lawsuit alleged that the clinic’s handling of Carter’s psychiatric care and the administration of these prescriptions contributed to the circumstances of his passing.

Details of the Wrongful Death Claim

The legal claim was centered on the argument that the psychiatry clinic failed to provide an adequate standard of care. The plaintiffs asserted that the prescriptions were managed improperly, leading to drug-linked complications.

The suit sought damages for the loss of parental support and the impact of the singer’s death on his young son.

While the specific financial terms of the agreement were not disclosed, the settlement resolves the claims of negligence brought against the medical facility.

Background on Aaron Carter’s Death

Aaron Carter died in December 2022 after being found unresponsive in a hotel room.

The medical examiner’s report identified the cause of death as cardiac arrest. The report further noted that the presence of alprazolam and hydrocodone in his system contributed to the fatal event.

The death was characterized as a drug-linked drowning, as the toxicity levels of the medications were linked to the singer’s inability to recover from the incident.

The settlement reached on May 14, 2026, addresses the role the prescribing clinic played in the availability of the medications cited in the autopsy.